MUMBAI, India, April 11 -- Intellectual Property India has published a patent application (202517003407 A) filed by Regel Therapeutics, Inc., Cambridge, U.S.A., on Jan. 15, for 'genetic regulatory elements and uses thereof.'
Inventor(s) include Dimidschstein, Jordane; Matharu, Navneet; Allaway, Kathryn; and Ziffra, Ryan.
The application for the patent was published on April 11, under issue no. 15/2025.
According to the abstract released by the Intellectual Property India: "Provided herein are regulatory elements capable of restricting the expression of a heterologous nucleotide sequence to specific neuronal populations and regions of the central nervous system (CNS). Further provided herein are vectors comprising such regulatory elements...